149 filings
Page 4 of 8
8-K
3s6tqvcags232
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
gds36o
29 Sep 21
Other Events
5:13pm
8-K
2nrgzqn60x
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
8-K
qpsus6x 2j
28 Jun 21
Other Events
6:07am
8-K
nr2bxj5rs1t0
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
y8ih52z
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
x8n886x2dz4xz b4
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
pzyfankzw8o06
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
pwsdh25c2c2ooboc29d
13 Apr 21
Other Events
4:06pm
DEFA14A
w2f0l6
6 Apr 21
Additional proxy soliciting materials
4:07pm
8-K
vvu9d 7trw6f
31 Mar 21
Other Events
4:05pm
8-K
pkkvqw4szm0yl9
30 Mar 21
Other Events
6:07am
S-8
xeg2 qnb2
25 Feb 21
Registration of securities for employees
5:30pm
8-K
isemtfydxk 151
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
6m1bm
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm